Part 2: The Necessary Changes that Sites, Institutions and Research Participants are Considering During the COVID-19 Crisis

May 14, 2020

Our panelists cover how clinical sites and institutions are making decisions about what research should continue during COVID-19, what resources site teams are utilizing to shift study visits to virtual and remote assessments, and what changes are being made to protocols based on site policies and precautions. Also presented is the participant perspective: how we can manage fear, change, and messages about “non-essential” research priorities.

Previous Flipbook
Part 3: Evaluating Study Status and Leveraging Data Monitoring Committees to Make Study Decisions
Part 3: Evaluating Study Status and Leveraging Data Monitoring Committees to Make Study Decisions

Next Flipbook
Part 1: Clinical Trials in the Era of COVID-19: Changes You Need to Make Now
Part 1: Clinical Trials in the Era of COVID-19: Changes You Need to Make Now